|
| Press Releases |
|
 |
|
| Tuesday, December 6, 2022 |
|
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
| Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
| Thursday, June 2, 2022 |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| more info >> |
|
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
| Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
| Thursday, September 30, 2021 |
|
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
| The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
| Friday, July 31, 2020 |
|
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
| Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
| Friday, July 24, 2020 |
|
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
| MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
| Tuesday, October 22, 2019 |
|
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
| Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
| Friday, June 28, 2019 |
|
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
| The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
| Friday, April 5, 2019 |
|
|
Passing of Dr Sydney Brenner, Nobel Laureate, Renowned Pioneer in Molecular Biology, A*Star Senior Fellow |
| It is with deep regret that the Agency for Science, Technology and Research (A*STAR) announces the passing of Dr Sydney Brenner, Honorary Singapore Citizen, and A*STAR Senior Fellow, early this morning. more info >> |
|
| Monday, January 21, 2019 |
|
|
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer |
| Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) in tumours can be targeted to prevent and treat cancer. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
GA-ASI Mojave Lights Up the Yuma Desert in Live-Fire Demonstration
Apr 23, 2024 20:00 HKT/SGT
|
|
|
2024 U.S. Open Polo Championship(R) Closes Out Historic High-Goal Season at the Sport's Premier Destination in Palm Beach County, Florida
Apr 23, 2024 20:00 HKT/SGT
|
|
|
HKTDC Home InStyle, Fashion InStyle forge global business opportunities
Apr 23, 2024 19:00 HKT/SGT
|
|
|
Masverse Unveils Groundbreaking Blockchain Platform 
Apr 23, 2024 18:00 HKT/SGT
|
|
|
Dubai Sets the Stage for Digital Innovation: Unveiling the Inaugural Digital Transformation Summit
Apr 23, 2024 17:56 HKT/SGT
|
|
|
New Contaminants, Food Testing & More: analytica Convention 2024 Focuses on Vietnam's Laboratory Needs
Apr 23, 2024 16:00 HKT/SGT
|
|
|
Singapore Unveils Its First Live Painting Event Featuring ADHD Artists, Inspired by 'Collide' by Tay Guan Hin"
Apr 23, 2024 14:28 HKT/SGT
|
|
|
EM2AI Revolutionising the Dental Industry: New AI Products Promise Transparent Treatment Plans for Patients
Apr 23, 2024 14:00 HKT/SGT
|
|
|
Vietnam: Nutifood opts for innovative SIG DomeMini on-the-go carton bottle
Apr 23, 2024 14:00 HKT/SGT
|
|
|
Citi, UBS, GS view positive on Fosun's core business-focused strategy
Apr 23, 2024 12:28 HKT/SGT
|
|
|
Indonesia Ready to Lead Water Governance Transformation at the 10th World Water Forum
Apr 23, 2024 12:00 HKT/SGT
|
|
|
(Second overseas roadshow of 2024) MGTO unveils mega roadshow and presentation seminar in Singapore this Thursday (25 April) to tap into overseas markets
Apr 23, 2024 10:00 HKT/SGT
|
|
|
Beyond Centralization: Exploring a New Era at the World Blockchain Summit
Apr 23, 2024 09:47 HKT/SGT
|
|
|
Fujitsu SX Survey reveals key success factors for sustainability
Apr 23, 2024 10:25 JST
|
|
|
Indonesia Ready to Lead Water Governance Transformation at the 10th World Water Forum
Apr 23, 2024 06:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
